Skip to content

Insider · CIK 0001610064

Alvin Shih

director

Files at ZVRA (ZEVRA THERAPEUTICS, INC.). First filing Sep 15, 2025, latest Sep 15, 2025.

In brief

Alvin Shih files SEC Form 4 as director at ZVRA (ZEVRA THERAPEUTICS, INC.). Since Sep 15, 2025, Alvin Shih has reported 1 open-market buy worth $158k and 0 open-market sells worth $0, the latest filed on Sep 15, 2025.

A track record needs three past buys with six months of prices behind them; Alvin Shih has 0, so none is measured yet.

The newest scored trade: bought $158k of ZVRA on Sep 12, 2025, filed Sep 15, 2025, scored 50 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$158k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ZVRA: ZEVRA THERAPEUTICS, INC.

ZVRAOct 12, 2026 · close 11.32

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
ZVRAbuy 2
ZEVRA THERAPEUTICS, INC.
$158k
20,000 shares
-+18% from low-39% from high

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 4, 2026ZVRA
ZEVRA THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+30,000$0.00$030,000Jun 18, 2026
Sep 12, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
POpen-market purchase
Common Stock
+20,000$7.89$158k20,000Sep 15, 2025
May 29, 2025ZVRA
ZEVRA THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+30,000$0.00$030,000May 30, 2025
Jan 20, 2024ZVRA
ZEVRA THERAPEUTICS, INC.
AGrant or award
Stock Option (right to buy)derivative
+58,800$0.00$058,800Feb 2, 2024

Questions about Alvin Shih

Answered from the filings on this page, as of the latest one.

Is Alvin Shih buying or selling?

Not in the last 12 months. Alvin Shih's latest open-market trade on SEC Form 4 was bought $158k of ZVRA on Sep 12, 2025.

How did Alvin Shih's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alvin Shih has 0.

Where does Alvin Shih file Form 4?

Alvin Shih has filed Form 4 at ZVRA (ZEVRA THERAPEUTICS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Alvin Shih: insider trades and track record | InsiderTell